Interim Susceptibility Testing for Ceftaroline (CPT), a Novel MRSA-Active Cephalosporin: Selecting Potent Surrogate ß-Lactam Markers to Predict CPT Activity against Clinically Indicated Species
Interim Susceptibility Testing for Ceftaroline (CPT), a Novel MRSA-Active Cephalosporin: Selecting Potent Surrogate ß-Lactam Markers to Predict CPT Activity against Clinically Indicated Species, Lead author: Jones RN, presented at 112th annual American Society for Microbiology General Meeting (ASM), June 16 – 19, 2012, San Francisco, CA
